4
Changes in Ownership
Cellectar Biosciences, Inc. Filed Acc 0001144204-19-044252
Options or other derivatives
- Chief Financial Officer acquired 90,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Elefant Dov Chief Financial Officer | 2019-09-10 | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | D | ||
Loading xslF345X03/tv529248_4.xml…